MitoPrime’s API, L-ergothioneine, is being used, or seriously investigated, for the following conditions:
- Cardiovascular health
- Neuro-degenerative diseases
- Ocular health
- Kidney health
- Lung function
- Obesity
- Type II diabetes
- PTSD
- Mitochondrial diseases
- Cancer
- Immune diseases
- Anxiety
- OCD
- Parkinson’s disease
- Huntington’s disease
- COPD